Onzima Ventures Share Discussion Threads

[fido] 24/7/2016 20:34

Or maybe you should just talk to the shareholders of some of Burnells failed companies to tell them how he is going to make your fortune.
See what sort of reaction you get for your hopes and dreams of riches.
You talk of Nigel having been there and done it, well so has Burnell and there are a lot of shareholders holding huge losses as a result.

[fido] 24/7/2016 20:29

PC
People losing their cash is NOT subject to reformulation, when its gone its gone.

[fido] 24/7/2016 20:27

Its also like lying when everyone knows you are a lier.
What`s the point.

[bigego] 24/7/2016 20:26

Dave this afternoon before the ONZ rage took hold.

[patientcapital] 24/7/2016 20:26

Fido, just relax and see how it all pans out. Life really is too short, far too short, to keep on in the manner in which you are.No doubt N4zima (geddit?) will likely have a reformulated treatment for you in due course.

[bigego] 24/7/2016 20:25

Its like having a fight with a blind cripple, you are hardly even worth the effort.

[fido] 24/7/2016 20:22

Must read.

[bigego] 24/7/2016 20:20

For anyone reading this just check out the Nigel Theobald Interview.

hxxp://www.momentousevents.uk/video_library.html

Hard to believe ONZ have 49% of N4 with such blue sky potential and the current mcap is still sub £3m.

Double figure market caps are coming here soon.

[bigego] 24/7/2016 20:18

Davey Boy, just how angry are you poppet?

Such a nasty little man, bet you have some form of severe issue, likely a childhood thing I guess, poor upbringing or worse.

[bigego] 24/7/2016 20:14

Been on the super strength again this afternoon or are you more of a meths man these days?

[fido] 24/7/2016 20:11

keya5000,
Do you not think the shareholders in Burnells write offs also had high hopes of riches but ended up pennyless.
But of course ONZ is the exception to the rule isn`t it.

[fido] 24/7/2016 20:08

keya5000,
Your right, if this follows the same course as the other Burnell disasters.

[keya5000] 24/7/2016 20:03

You are without doubt the most bitter individual I have ever come across.

I have me a lot of people in my time but I am honestly lost for words to describe the pure bitterness and hatred you have towards this company.

Stay with us for the ride I think you will enjoy it.

[keya5000] 24/7/2016 20:00

Calm down darling. Have you started on the sauce a tad earlier today.

What have SAR got. What have MTFB got. What have AMYRT got. Yes nothing but potential but have some of that potential priced in.

When N4 get a deal and they are looking for one now the first stage of the rerate will occur and then so on.

Stay with us for the ride.

[fido] 24/7/2016 19:58

You believe, is that another phrase for I made it up.

[keya5000] 24/7/2016 19:52

thoughts below of an associate who holds an interest in ONZ covers the near term drivers very well. We all know this depends on the success of N4 but the main man has been there and done it before. Good chance we will see history repeat itself.

I asked Nigel Theobald why he left his previous company. He replied that he left because he thinks he can do better with n4.

That's good enough for me.

---------

I think the drivers for the ONZ share price catalysed by N4 are (in a very rough chronological order – although as you know it’s all highly uncertain!):

-Further patent filings for other potential drugs that can be reformulated b N4’s platforms (although admittedly these will not be major share price drivers, these announcements will help to paint a picture of the range of revenue streams that N4 could enjoy in the longer term)
-Results on sildenafil PoC studies
-Securing a major pharma as a partner in bringing a reformulated sildenafil to market. Ideally we’ll see the partner entirely funding the development whilst taking a big portion of future revenue share. This process of seeking a partner for sildenafil was commenced three months ago
-Securing a major partner for the Cocrys platform as a whole
-Grant funding for Nuvac and/or Nuvec platforms (again staves off equity dilution to N4 (and thus to ONZ), something that private investors love). These two appear slightly behind Cocrys in terms of development
-Results on further testing of Nuvac/Nuvec platforms
-Securing a major partner to fund the further development of these platforms
-Announcement of next major product to be developed on the platforms after sildenafil

Beyond these specific catalysts, what I really like about the N4 story is:

-Nigel’s track record in the space
-Nigel’s belief in the potential of the platforms that he has created (as evinced by his share purchases in placings and on the open market)
-The business model (circa £3m in total per reformulation of a particular product, and the short time to market (2.5-3 years); which if successful can result in annual sales for any particular product of many tens of millions of £)
-The likely route to market via ONZ. An RTO is the very obvious move here, with ONZ enjoying a bargaining chip via its existing loan note (which will likely be made convertible at the time of RTO, along with the issuance of consideration shares for Nigel and a placing of new shares to fund the next two years of ops). I don’t think this will occur until news of a partnership with a major comes, at which point the RTO can be achieved at a materially higher share price
-The obvious takeover target that N4 represents (specifically, by Pfizer, given that sildenafil is N4’s first drug it is reformulating. I picture Pfizer taking out all of N4 and first and foremost using the reformulated sildenafil to simply ‘refresh’; its market leading Viagra brand (“Viagra XL”?!))

I’m also getting increasingly confident that a second (and potentially third) biopharma investment will be made in the near future.

The rationale for this is based on:
- our CEO hinting at increasing exposure to the space (in the Year End results);
- the creation of the two divisions, asset trading and business development (were only one long term investment to be made and held, I feel that the creation of the B.D. division would have been largely pointless);
- our directors not having bought stock on the open market. Inside?


So news on this front likewise has the potential to act as a significant share price driver for ONZ.

I believe cash burn is currently circa £15k per month, so there’s ample leg room before any fundraise is required. Indeed, it would seem that the Asset Trading division is covering all corporate overheads!

[keya5000] 24/7/2016 19:45

Just watched the momentous events video again.

£300m+ mcap company in the making.

Just buy hold and reap the rewards when the n4 news flow ramps up.

It is all happening.

[keya5000] 24/7/2016 18:16

Dave we are all very happy with our investment here just a shame we have to put up with the rantings of a moron like you 24/7.

Suspect At some point you will give up. I reckon about 2.5p which will be 400% up from when your futile crusade started will be the point.